Cochlear OTC Stock Valuation

CHEOY -  USA Stock  

USD 81.50  1.36  1.70%

Do you wonder what the value of Cochlear is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Cochlear, is its stock price multiplied by the total number of shares outstanding, calculating Cochlear's enterprise value requires a different approach. It uses Cochlear's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Cochlear shows a prevailing Real Value of $74.58 per share. The current price of the firm is $81.5. At this time, the firm appears to be overvalued. Our model approximates the value of Cochlear from analyzing the firm fundamentals such as return on equity of 21.04 %, and Profit Margin of 21.80 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Cochlear Valuation 

 
Refresh
Cochlear Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Cochlear's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Overvalued
Today
81.50
19th of October 2021
Share
Please note that Cochlear's price fluctuation is very steady at this time. Calculation of the real value of Cochlear is based on 3 months time horizon. Increasing Cochlear's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Cochlear is useful when determining the fair value of the Cochlear otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Cochlear. Since Cochlear is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cochlear OTC Stock. However, Cochlear's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
74.58
Real Value
101.50
Upside
Estimating the potential upside or downside of Cochlear helps investors to forecast how Cochlear otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cochlear more accurately as focusing exclusively on Cochlear's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimated ValueHigh
92.2792.2792.27
Details

Cochlear Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Cochlear's current stock value. Our valuation model uses many indicators to compare Cochlear value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cochlear competition to find correlations between indicators driving Cochlear's intrinsic value. More Info.
Cochlear is rated below average in beta category among related companies. It is rated fourth in price to book category among related companies fabricating about  19.42  of Price to Book per Beta.

About Cochlear Valuation

The equity valuation mechanism determines the current worth of Cochlear on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Cochlear. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cochlear based exclusively on its fundamental and basic technical indicators. By analyzing Cochlear's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Cochlear's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cochlear. We calculate exposure to Cochlear's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cochlear's related companies.
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia. Cochlear operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4000 people.

Cochlear Dividends Analysis For Valuation

There are various types of dividends Cochlear can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Cochlear shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Cochlear directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Cochlear pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Cochlear by the value of the dividends paid out.

Cochlear Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Cochlear does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio2.42
Revenue Growth33.50%
Payout Ratio23.63%
Enterprise Value To Ebitda28.42
Enterprise Value To Revenue7.32
Continue to Trending Equities. Note that the Cochlear information on this page should be used as a complementary analysis to other Cochlear's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Cochlear OTC Stock analysis

When running Cochlear price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
The market value of Cochlear is measured differently than its book value, which is the value of Cochlear that is recorded on the company's balance sheet. Investors also form their own opinion of Cochlear's value that differs from its market value or its book value, called intrinsic value, which is Cochlear's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cochlear's market value can be influenced by many factors that don't directly affect Cochlear underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cochlear's value and its price as these two are different measures arrived at by different means. Investors typically determine Cochlear value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cochlear's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.